Cardiovascular Systems Inc (CSII)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Scott R. Ward
Employees:
780
1225 OLD HWY 8 NW, ST. PAUL, MN 55112
651-259-1600

Cardiovascular Systems, Inc. develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products, which are catheter-based platforms to treat various plaque types in above and below the knee. It also provides Diamondback 360 Coronary orbital atherectomy systems, a coronary artery disease (CAD) product.

Data derived from most recent annual or quarterly report
Market Cap 527.352 Million Shares Outstanding40.785 Million Avg 30-day Volume 296.975 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.35
Price to Revenue2.3848 Debt to Equity0.0 EBITDA-29.537 Million
Price to Book Value2.2581 Operating Margin-15.157799999999998 Enterprise Value370.081 Million
Current Ratio6.053 EPS Growth-1.686 Quick Ratio4.994
1 Yr BETA 1.084 52-week High/Low 36.97 / 12.51 Profit Margin-15.6349
Operating Cash Flow Growth-2645.7014 Altman Z-Score3.8962 Free Cash Flow to Firm -38.023 Million
Earnings Report2022-11-08
View SEC Filings from CSII instead.

View recent insider trading info

Funds Holding CSII (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CSII

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-08-03:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-22:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-06-07:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-05-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-30:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
  • 8-K: filed on 2022-03-03:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2021-11-12:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2021-11-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-09-22:
    Item 7.01: Regulation FD Disclosure
  • Prospectus

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    2.4 Thousand total shares from 1 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    WARD SCOTT R. CHAIRMAN AND CEO

    • Officer
    • Director
    841,735 2022-08-18 5

    ROSENSTEIN ALEXANDER GENERAL COUNSEL & CORP. SEC.

    • Officer
    144,580 2022-08-18 4

    SEDO SANDRA CHIEF COMPLIANCE OFFICER

    • Officer
    110,558 2022-08-18 5

    POINTS JEFFREY S. CHIEF FINANCIAL OFFICER

    • Officer
    168,915 2022-08-18 5

    REMPE STEPHEN J. CHIEF HUMAN RESOURCES OFFICER

    • Officer
    79,401 2022-08-18 5

    ARONSON MARTHA GOLDBERG

    • Director
    42,227 2022-08-15 3

    HASTINGS JOHN M. VP MANUFACTURING & OPERATIONS

    • Officer
    53,652 2022-08-12 2

    LAWLOR AUGUSTINE

    • Director
    134,059 2022-08-05 2

    COHN WILLIAM E.

    • Director
    50,002 2022-08-05 1

    PAULSEN ERIK

    • Director
    21,327 2022-08-05 2

    STENBECK STEPHEN

    • Director
    22,853 2022-08-05 1

    WOMACK KELVIN K.

    • Director
    16,734 2022-08-05 1

    JAIN SACHIN H.

    • Director
    15,658 2022-08-05 1

    EGELAND RYAN CHIEF MEDICAL OFFICER

    • Officer
    76,180 2022-02-08 1

    WHITESCARVER DAVID VP OF CORP. DEV. AND IP

    • Officer
    63,264 2022-02-08 2

    ROBB RHONDA J. CHIEF OPERATING OFFICER

    • Officer
    169,581 2022-02-07 1

    BROWN EDWARD M

    • Director
    202,076 2021-08-09 0

    BLACKEY BRENT G

    • Director
    94,332 2019-09-03 0

    GILLUND LAURA CHIEF TALENT OFFICER

    • Officer
    104,197 2018-08-28 0

    BARTOS SCOTT A.

    • Director
    1,699 2018-08-28 0

    BETTERLEY LAURENCE L CHIEF FINANCIAL OFFICER

    • Officer
    221,749 2017-08-15 0

    KENNY KEVIN J. CHIEF OPERATING OFFICER

    • Officer
    151,280 2017-08-15 0

    KOEHN PAUL A. SVP MANUFACTURING & OPERATIONS

    • Officer
    83,989 2017-05-31 0

    TRIGG LESLIE

    • Director
    17,282 2016-11-18 0

    CAMBER CAPITAL MANAGEMENT LLC

    • 10% Owner
    No longer subject to file 2016-09-19 0

    MARTIN DAVID PRESIDENT AND CEO

    • Officer
    • Director
    481,607 2015-10-08 0

    THATCHER ROBERT J. CHIEF HEALTHCARE POLICY OFF'R

    • Officer
    126,978 2015-10-02 0

    NELSON GLEN D

    • Director
    1,399,345 2014-08-11 0

    FLAHERTY JAMES E CHIEF ADMINISTRATIVE OFFICER

    • Officer
    114,177 2014-05-01 0

    FRIEDMAN JOHN H

    • Director
    701,687 2013-11-07 0

    DISCOVERY GROUP I, LLC

    DONOGHUE DANIEL J

    MURPHY MICHAEL R

    • 10% Owner
    2,027,658 2012-07-17 0

    HARTZLER GEOFFREY O

    • Director
    116,888 2011-08-08 0

    KRAUS SCOTT WILLIAM VP SALES

    • Officer
    63,871 2011-07-19 0

    DOUGHTY BRIAN VP OF COMMERICAL OPERATIONS

    • Officer
    58,914 2011-05-12 0

    MAVERICK CAPITAL LTD

    MAVERICK CAPITAL MANAGEMENT LLC

    AINSLIE LEE S III

    • 10% Owner
    No longer subject to file 2010-11-30 0

    TYSKA PAUL A VP OF BUSINESS DEV

    • Officer
    46,821 2010-08-13 0

    HOWE ROGER J

    • Director
    0 2010-08-13 0

    PETRUCCI GARY M

    • Director
    255,036 2009-12-02 0

    TARRANT ADVISORS, INC

    BONDERMAN DAVID

    COULTER JAMES G

    • FORMER 10% OWNER (1) (2)FORMER 10% OWNER (1) (2)FORMER 10% OWNER (1) (2)
    No longer subject to file 2009-02-25 0

    DUYK GEOFFREY M

    • FORMER DIRECTOR (1)
    No longer subject to file 2009-02-25 0

    WYSKIEL CHRISTINA W

    • Director
    No longer subject to file 2009-02-25 0

    WHITEBOX HEDGED HIGH YIELD PARTNERS, L.P.

    • LESS THAN 10% OWNER
    0 2008-12-31 0

    MITSUI & CO. VENTURE PARTNERS II, L.P.

    MITSUI & CO. VENTURE PARTNERS, INC. PRESIDENT AND CEO

    MITSUI & CO LTD GENERAL MANAGER

    • Officer
    • 10% Owner
    0 2008-12-29 0

    EASTON HUNT CAPITAL PARTNERS LP

    • 10% Owner
    0 2008-12-29 0

    EASTON CAPITAL PARTNERS L P

    • 10% Owner
    0 2008-12-29 0

    KALLOK MICHAEL J CHIEF SCIENTIFIC OFFICER

    • Officer
    • Director
    • MBR OF 13(D) GRP OWNG > 10%
    5,500 2008-12-29 0

    BORRELL JOHN R VP OF SALES

    • Officer
    • MBR OF 13(D) GRP OWNG > 10%
    23,000 2008-12-29 0

    MITCHELL DANIEL J

    • Director
    1,539,931 2008-12-12 0

    MORRISSEY DONALD J JR SR. VP, CORPORATE DEVELOPMENT

    • Officer
    70,258 2008-12-04 0

    CALHOUN KIRK K

    • Director
    0 2008-05-08 0

    ECHOLS ROGER CHIEF MEDICAL OFFICER

    • Officer
    46,957 2007-11-01 0

    LETENDRE PETER CHIEF COMMERCIAL OFFICER

    • Officer
    6,179 2007-06-29 0

    EARL CHRISTOPHER

    • Director
    8,156 2007-05-10 0

    WENDT HENRY

    • Director
    1,052,983 2007-03-08 0

    SMITH MARK L CFO AND TREASURER

    • Officer
    90,000 2007-03-08 0

    JANJIC NEBOJSA CHIEF SCIENTIFIC OFFICER, SEC.

    • Officer
    90,000 2007-03-08 0

    COLLINS KENNETH J PRESIDENT AND CEO

    • Officer
    • Director
    100,000 2007-03-08 0

    HEALTHCARE VENTURES VI LP

    HEALTHCARE PARTNERS VI LP

    CAVANAUGH JAMES H

    LITTLECHILD JOHN W

    WERNER HAROLD R

    MIRABELLI CHRISTOPHER

    AGUIAR ERIC

    CROUSE WILLIAM W

    • 10% Owner
    3,612,362 2006-07-03 0

    CHRISTOFFERSEN RALPH E

    • Director
    16,313 2006-06-28 0

    MORGENTHALER PARTNERS VII LP

    • 10% Owner
    0 2006-06-27 0

    TARRANT ADVISORS, INC

    • 10% Owner
    0 2006-06-27 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    REMPE STEPHEN J. - Officer CHIEF HUMAN RESOURCES OFFICER

    2022-08-23 16:13:14 -0400 2022-08-18 D 6,175 d 79,401 direct 2.3304 -9.4585 2.3304 2 -9.4585 6

    POINTS JEFFREY S. - Officer CHIEF FINANCIAL OFFICER

    2022-08-23 16:10:37 -0400 2022-08-18 D 12,752 d 168,915 direct 2.3304 -9.4585 2.3304 2 -9.4585 6

    WARD SCOTT R. - Director - Officer CHAIRMAN AND CEO

    2022-08-23 16:11:33 -0400 2022-08-18 D 77,028 d 807,438 direct 2.3304 -9.4585 2.3304 2 -9.4585 6

    SEDO SANDRA - Officer CHIEF COMPLIANCE OFFICER

    2022-08-23 16:08:38 -0400 2022-08-18 D 9,873 d 110,558 direct 2.3304 -9.4585 2.3304 2 -9.4585 6

    ROSENSTEIN ALEXANDER - Officer GENERAL COUNSEL & CORP. SEC.

    2022-08-23 16:09:40 -0400 2022-08-18 D 10,955 d 144,580 direct 2.3304 -9.4585 2.3304 2 -9.4585 6

    ARONSON MARTHA GOLDBERG - Director

    2022-08-17 16:14:28 -0400 2022-08-15 M 2,411 d 0 direct

    ARONSON MARTHA GOLDBERG - Director

    2022-08-17 16:14:28 -0400 2022-08-15 M 2,411 a 12,411 direct -5.3125 -6.6875 0.0 1 -9.4375 4

    REMPE STEPHEN J. - Officer CHIEF HUMAN RESOURCES OFFICER

    2022-08-16 20:57:17 -0400 2022-08-12 F 2,005 $16.64 d 85,576 direct -1.1736 -9.8826 0.0 1 -10.5003 5

    ROSENSTEIN ALEXANDER - Officer GENERAL COUNSEL & CORP. SEC.

    2022-08-16 20:54:29 -0400 2022-08-12 F 2,601 $16.64 d 155,535 direct -1.1736 -9.8826 0.0 1 -10.5003 5

    SEDO SANDRA - Officer CHIEF COMPLIANCE OFFICER

    2022-08-16 20:55:14 -0400 2022-08-12 F 1,942 $16.64 d 120,431 direct -1.1736 -9.8826 0.0 1 -10.5003 5

    WARD SCOTT R. - Director - Officer CHAIRMAN AND CEO

    2022-08-16 20:56:07 -0400 2022-08-12 F 16,006 $16.64 d 884,466 direct -1.1736 -9.8826 0.0 1 -10.5003 5

    HASTINGS JOHN M. - Officer VP MANUFACTURING & OPERATIONS

    2022-08-16 20:52:55 -0400 2022-08-12 F 1,628 $16.64 d 53,652 direct -1.1736 -9.8826 0.0 1 -10.5003 5

    POINTS JEFFREY S. - Officer CHIEF FINANCIAL OFFICER

    2022-08-16 20:53:39 -0400 2022-08-12 F 3,308 $16.64 d 181,667 direct -1.1736 -9.8826 0.0 1 -10.5003 5

    REMPE STEPHEN J. - Officer CHIEF HUMAN RESOURCES OFFICER

    2022-08-09 16:22:31 -0400 2022-08-05 A 28,427 a 87,581 direct 0.0614 -0.5528 -20.4545 5.4668 4 -20.516 30

    POINTS JEFFREY S. - Officer CHIEF FINANCIAL OFFICER

    2022-08-09 16:23:19 -0400 2022-08-05 A 56,747 a 184,975 direct 0.0614 -0.5528 -20.4545 5.4668 4 -20.516 30

    POINTS JEFFREY S. - Officer CHIEF FINANCIAL OFFICER

    2022-08-09 16:23:19 -0400 2022-08-05 A 18,916 a 128,228 direct 0.0614 -0.5528 -20.4545 5.4668 4 -20.516 30

    LAWLOR AUGUSTINE - Director

    2022-08-09 16:18:56 -0400 2022-08-05 A 9,064 a 9,064 direct

    REMPE STEPHEN J. - Officer CHIEF HUMAN RESOURCES OFFICER

    2022-08-09 16:22:31 -0400 2022-08-05 A 9,476 a 58,928 direct 0.0614 -0.5528 -20.4545 5.4668 4 -20.516 30

    ROSENSTEIN ALEXANDER - Officer GENERAL COUNSEL & CORP. SEC.

    2022-08-09 16:21:00 -0400 2022-08-05 A 43,040 a 158,136 direct 0.0614 -0.5528 -20.4545 5.4668 4 -20.516 30

    ROSENSTEIN ALEXANDER - Officer GENERAL COUNSEL & CORP. SEC.

    2022-08-09 16:21:00 -0400 2022-08-05 A 14,347 a 115,096 direct 0.0614 -0.5528 -20.4545 5.4668 4 -20.516 30

    SEDO SANDRA - Officer CHIEF COMPLIANCE OFFICER

    2022-08-09 16:20:02 -0400 2022-08-05 A 30,770 a 122,373 direct 0.0614 -0.5528 -20.4545 5.4668 4 -20.516 30

    SEDO SANDRA - Officer CHIEF COMPLIANCE OFFICER

    2022-08-09 16:20:02 -0400 2022-08-05 A 10,257 a 91,603 direct 0.0614 -0.5528 -20.4545 5.4668 4 -20.516 30

    ARONSON MARTHA GOLDBERG - Director

    2022-08-09 16:18:01 -0400 2022-08-05 A 9,064 a 9,064 direct

    PAULSEN ERIK - Director

    2022-08-09 16:17:08 -0400 2022-08-05 A 9,064 a 9,064 direct

    STENBECK STEPHEN - Director

    2022-08-09 16:16:01 -0400 2022-08-05 A 9,064 a 9,064 direct

    WOMACK KELVIN K. - Director

    2022-08-09 16:12:58 -0400 2022-08-05 A 9,064 a 9,064 direct

    JAIN SACHIN H. - Director

    2022-08-09 16:12:12 -0400 2022-08-05 A 9,064 a 9,064 direct

    COHN WILLIAM E. - Director

    2022-08-09 16:11:16 -0400 2022-08-05 A 9,064 a 9,064 direct

    COHN WILLIAM E. - Director

    2022-08-09 16:11:16 -0400 2022-08-05 A 3,626 a 9,449 direct 0.0614 -0.5528 -20.4545 5.4668 4 -20.516 30

    WARD SCOTT R. - Director - Officer CHAIRMAN AND CEO

    2022-08-09 16:24:36 -0400 2022-08-05 A 239,819 a 900,472 direct 0.0614 -0.5528 -20.4545 5.4668 4 -20.516 30

    WARD SCOTT R. - Director - Officer CHAIRMAN AND CEO

    2022-08-09 16:24:36 -0400 2022-08-05 A 79,940 a 660,653 direct 0.0614 -0.5528 -20.4545 5.4668 4 -20.516 30

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    CARDIOVASCULAR SYSTEMS INC CSII 2022-09-23 22:15:03 UTC 0.7774 2.2926 150000
    CARDIOVASCULAR SYSTEMS INC CSII 2022-09-23 21:45:03 UTC 0.1081 2.9619 150000
    CARDIOVASCULAR SYSTEMS INC CSII 2022-09-23 21:15:03 UTC 0.1081 2.9619 150000
    CARDIOVASCULAR SYSTEMS INC CSII 2022-09-23 20:45:03 UTC 0.1081 2.9619 150000
    CARDIOVASCULAR SYSTEMS INC CSII 2022-09-23 20:15:06 UTC 0.1081 2.9619 150000
    CARDIOVASCULAR SYSTEMS INC CSII 2022-09-23 19:45:03 UTC 0.1081 2.9619 150000
    CARDIOVASCULAR SYSTEMS INC CSII 2022-09-23 19:15:03 UTC 0.1081 2.9619 150000
    CARDIOVASCULAR SYSTEMS INC CSII 2022-09-23 18:45:03 UTC 0.1081 2.9619 150000
    CARDIOVASCULAR SYSTEMS INC CSII 2022-09-23 18:15:04 UTC 0.1081 2.9619 150000
    CARDIOVASCULAR SYSTEMS INC CSII 2022-09-23 17:45:04 UTC 0.1081 2.9619 150000
    CARDIOVASCULAR SYSTEMS INC CSII 2022-09-23 17:15:04 UTC 0.1081 2.9619 150000
    CARDIOVASCULAR SYSTEMS INC CSII 2022-09-23 16:45:03 UTC 0.0368 3.0332 150000
    CARDIOVASCULAR SYSTEMS INC CSII 2022-09-23 16:15:03 UTC 0.0368 3.0332 150000
    CARDIOVASCULAR SYSTEMS INC CSII 2022-09-23 15:45:03 UTC 0.0368 3.0332 150000
    CARDIOVASCULAR SYSTEMS INC CSII 2022-09-23 15:15:03 UTC 0.0368 3.0332 150000
    CARDIOVASCULAR SYSTEMS INC CSII 2022-09-23 14:45:03 UTC -0.329 2.649 150000
    CARDIOVASCULAR SYSTEMS INC CSII 2022-09-23 14:15:03 UTC -0.329 2.649 150000
    CARDIOVASCULAR SYSTEMS INC CSII 2022-09-23 13:45:03 UTC -0.329 2.649 1100000
    CARDIOVASCULAR SYSTEMS INC CSII 2022-09-23 13:15:03 UTC -0.329 2.649 1400000
    CARDIOVASCULAR SYSTEMS INC CSII 2022-09-23 12:45:03 UTC -0.329 2.649 1400000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Trust for Professional Managers- Convergence Market Neutral Fund CSII -3519.0 shares, $-114965.73 2020-08-31 N-PORT
    FundVantage Trust- Gotham Enhanced Index Plus Fund CSII -41.0 shares, $-1443.61 2020-03-31 N-PORT
    FundVantage Trust- Gotham Index Plus All-Cap Fund CSII -78.0 shares, $-2746.38 2020-03-31 N-PORT

    Elevate your investments